Results 161 to 170 of about 19,872,848 (346)
Evolution and Future Prospects of Nurse Anaesthetists in Catalonia: Inception, Upskilling and Scope of Practice. [PDF]
Sanclemente-Dalmau M+5 more
europepmc +1 more source
The Role of the Krebs Cycle in Conjugation in Escherichia coli K-12
K W Fisher
openalex +1 more source
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain+3 more
wiley +1 more source
Stepping into the role of a doctor: an instrumental case study to explore the experiences of third-year medical students in a simulated general practice clinic. [PDF]
Jakeways N, Markless S, Hearn R.
europepmc +1 more source
ROLE OF COAGULASE REACTING FACTOR IN THE ACTIVATION OF FIBRINOGEN [PDF]
Marvin Murray, Paul Gohdes
openalex +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source
He said, she said: the "accused" and "complainant" in a sexual assault scenario are equally susceptible to misinformation. [PDF]
Greene CM, Brassil M, Murphy G.
europepmc +1 more source
CHOLESTEROL BIOSYNTHESIS. STUDIES RELATED TO THE METABOLIC ROLE OF SQUALENE1 [PDF]
Maxwell L. Eidinoff+5 more
openalex +1 more source
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu+11 more
wiley +1 more source